Safety Shot Reports Notice Of Allowance Of New Patent To Secure IP And Enforce Clinically Backed Claims
Portfolio Pulse from Benzinga Newsdesk
Safety Shot has received a Notice of Allowance for a new patent, enhancing its intellectual property portfolio. This patent supports the company's formulations that rapidly reduce blood alcohol content, reinforcing its clinically backed claims.
September 06, 2024 | 12:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Safety Shot has been granted a Notice of Allowance for a new patent, which strengthens its intellectual property and supports its product claims. This development could enhance the company's market position and credibility.
The new patent approval is a significant development for Safety Shot as it enhances the company's intellectual property portfolio. This strengthens the company's position in the market by supporting its claims about its product's effectiveness in reducing blood alcohol content. Such developments are likely to positively influence investor sentiment and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90